ADEN — ADENTRA Income Statement
0.000.00%
- CA$685.89m
- CA$1.50bn
- $2.18bn
- 85
- 92
- 21
- 73
Annual income statement for ADENTRA, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 928 | 1,616 | 2,580 | 2,239 | 2,184 |
Cost of Revenue | |||||
Gross Profit | 179 | 373 | 557 | 466 | 474 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 885 | 1,468 | 2,383 | 2,147 | 2,087 |
Operating Profit | 43.7 | 148 | 197 | 92.3 | 96.9 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 38 | 138 | 163 | 42.9 | 55.3 |
Provision for Income Taxes | |||||
Net Income After Taxes | 28 | 103 | 129 | 36 | 46.5 |
Net Income Before Extraordinary Items | |||||
Net Income | 28 | 103 | 129 | 36 | 46.5 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 28 | 103 | 129 | 36 | 46.5 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.39 | 4.91 | 5.48 | 1.59 | 1.92 |
Dividends per Share |